Genetic ablation of Aldh1a1 (encoding RALDH1) and administration of RALDH inhibitors increase tissue levels of retinaldehyde and protect against diet-induced obesity and diabetes [160,161]. Here, ALDH1A1 is linked to obesity due to melanocortin 4 receptor deficiency.